Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8736409rdf:typepubmed:Citationlld:pubmed
pubmed-article:8736409lifeskim:mentionsumls-concept:C0342786lld:lifeskim
pubmed-article:8736409lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:8736409lifeskim:mentionsumls-concept:C2827424lld:lifeskim
pubmed-article:8736409pubmed:issue3lld:pubmed
pubmed-article:8736409pubmed:dateCreated1996-12-13lld:pubmed
pubmed-article:8736409pubmed:abstractTextFour patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency are presented. Clinical onset in the form of acute encephalopathy occurred between the ages of 9 months and 3 years. The clinical course included recurrent metabolic crises in 4 patients, cardiac involvement and retinopathy in 3, and myopathy in 2. None had signs of peripheral neuropathy. Three patients died and one is currently well. Hypoketotic hypoglycemia with C6-C14 3-hydroxy-dicarboxylic aciduria during metabolic crises associated with decreased plasma carnitine levels was the main biochemical finding. Enzymologic studies disclosed long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency in all patients. Homozygosity for a G to C mutation at position 1528 in the encoding region of the enzyme was found in 2 patients. Histologic and electron microscopic studies of liver biopsy specimens revealed steatosis in 3 patients and mitochondrial abnormalities in 2. Skeletal muscle biopsies disclosed nonspecific degenerative changes in 2 patients and were normal in the remaining 2. Ultrastructural abnormalities in mitochondria were found in 3 patients. A review of the literature combined with the data from our series (total 22 patients) disclosed acute clinical onset in 77% of cases and subacute in 23%. In the combined series, the average age at onset was 11 months, family history was positive in 32% of patients and overall mortality was 50%. We describe the clinical spectrum of this disease and emphasize that, among patients with suspected beta-oxidation defects the finding of pigmentary retinopathy should lead to the suspicion of long-chain 3-hydroxyacyl-coenzyme A-dehydrogenase deficiency.lld:pubmed
pubmed-article:8736409pubmed:languageenglld:pubmed
pubmed-article:8736409pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8736409pubmed:citationSubsetIMlld:pubmed
pubmed-article:8736409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8736409pubmed:statusMEDLINElld:pubmed
pubmed-article:8736409pubmed:monthAprlld:pubmed
pubmed-article:8736409pubmed:issn0887-8994lld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:PonsRRlld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:BrionesPPlld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:NavarroCClld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:WandersR JRJlld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:RiudorEElld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:RibesAAlld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:RoigMMlld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:BaldellouAAlld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:OlestiMMlld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:Gil-GibernauJ...lld:pubmed
pubmed-article:8736409pubmed:authorpubmed-author:OrtigosaLLlld:pubmed
pubmed-article:8736409pubmed:issnTypePrintlld:pubmed
pubmed-article:8736409pubmed:volume14lld:pubmed
pubmed-article:8736409pubmed:ownerNLMlld:pubmed
pubmed-article:8736409pubmed:authorsCompleteYlld:pubmed
pubmed-article:8736409pubmed:pagination236-43lld:pubmed
pubmed-article:8736409pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8736409pubmed:meshHeadingpubmed-meshheading:8736409-...lld:pubmed
pubmed-article:8736409pubmed:meshHeadingpubmed-meshheading:8736409-...lld:pubmed
pubmed-article:8736409pubmed:meshHeadingpubmed-meshheading:8736409-...lld:pubmed
pubmed-article:8736409pubmed:meshHeadingpubmed-meshheading:8736409-...lld:pubmed
pubmed-article:8736409pubmed:meshHeadingpubmed-meshheading:8736409-...lld:pubmed
pubmed-article:8736409pubmed:meshHeadingpubmed-meshheading:8736409-...lld:pubmed
pubmed-article:8736409pubmed:meshHeadingpubmed-meshheading:8736409-...lld:pubmed
pubmed-article:8736409pubmed:meshHeadingpubmed-meshheading:8736409-...lld:pubmed
pubmed-article:8736409pubmed:meshHeadingpubmed-meshheading:8736409-...lld:pubmed
pubmed-article:8736409pubmed:meshHeadingpubmed-meshheading:8736409-...lld:pubmed
pubmed-article:8736409pubmed:year1996lld:pubmed
pubmed-article:8736409pubmed:articleTitleThe clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.lld:pubmed
pubmed-article:8736409pubmed:affiliationChild Neurology Unit, Vall d'Hebron University Hospital, Barcelona, Spain.lld:pubmed
pubmed-article:8736409pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8736409pubmed:publicationTypeReviewlld:pubmed
pubmed-article:8736409pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:8736409pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8736409lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8736409lld:pubmed